Molecular Formula | C8H11NO2 |
Molar Mass | 153.18 |
Density | 1.1577 (rough estimate) |
Melting Point | 280 °C (dec.) (lit.) |
Boling Point | 276.1°C (rough estimate) |
Specific Rotation(α) | -154 º (c=1 in H2O) |
Flash Point | 122.8°C |
Solubility | Aqueous Acid (Slightly) |
Vapor Presure | 0.00107mmHg at 25°C |
Appearance | neat |
Color | White |
BRN | 2091420 |
pKa | 2.17±0.10(Predicted) |
Storage Condition | -20°C |
Refractive Index | -155 ° (C=1, 1mol/L |
MDL | MFCD00137746 |
Physical and Chemical Properties | Appearance: white or off-white powder |
Use | Used in the manufacture of cefradine. |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
Introduction | (R)-(-)-2-(2, 5-dihydrophenyl) glycine, commonly known as dihydrophenylglycine, is an important intermediate of cefradine, which is obtained by hydrogenation reduction of D(-)-phenylglycine. |
preparation | at present, the domestic production process of (R)-(-)-2-(2,5-dihydrophenyl) glycine is 1500~1700 L liquid ammonia mixed with 300~400 L water cooling (vacuum cooling with ammonia compressor or vacuum pump) to below -30 ℃, add 40 kgD(-)-phenylglycine, then add 22~32kg of metal sodium in batches, control the temperature below -15 ℃ for reaction for more than 1 h, recover liquid ammonia after the reaction, decolorize at 30 ℃ ~ 50 ℃ for more than 30 min, filter, adjust the pH to 6.5~6.8 with hydrochloric acid below 35 ℃, cool to below 15 ℃ and spin dry centrifugally, wash and spin dry with purified water, and dry with wet product air dryer. |
use | used as the main intermediate for the production of drug pioneer 6 |